Skip to main content
Log in

A review of the current evidence on the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus

  • Review Article
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

Aims

To evaluate the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus based on the current literature.

Methods

Three electronic databases were searched for eligible studies that investigated the sensitivity and specificity of the Ipswich touch test. Methodological quality was assessed using the QUADAS-2 tool.

Results

Five studies that reported the sensitivity and specificity of the Ipswich touch test were included. When compared to the 10 g monofilament, the sensitivity ranges from 51 to 83.3% and the specificity ranges from 96.4 to 98%. When compared to the vibration perception test ≥25 V, Ipswich touch test sensitivity ranges from 76 to 100% and specificity ranges from 90 to 96.6%.

Conclusions

The Ipswich touch test has a high specificity in screening for loss of protective sensation in the feet of patients with diabetes mellitus. It is a useful test to be included in diabetic foot screenings, especially when other sensory tools are not available. However, more rigorous studies need to be conducted as there is currently only a limited pool of research evidence to substantiate it as a screening tool for loss of protective sensation in the diabetic foot.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Tesfaye S, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–93. https://doi.org/10.2337/dc10-1303.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Won JC, Park TS. Recent advances in diagnostic strategies for diabetic peripheral neuropathy. Endocrinol Metab. 2016;31(2):230–8.

    Article  CAS  Google Scholar 

  3. Amin N, Doupis J. Diabetic foot disease: from the evaluation of the ‘foot at risk’ to the novel diabetic ulcer treatment modalities. World J Diabetes. 2016;7(7):153–64. https://doi.org/10.4239/wjd.v7.i7.153.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Juster-Switlyk K, Smith AG. Updates in diabetic peripheral neuropathy. F1000Research. 2016. https://doi.org/10.12688/f1000research.7898.1.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Craig AB, Strauss MB, Daniller A, Miller SS. Foot sensation testing in the patient with diabetes: introduction of the quick and easy assessment tool. Wounds Compend Clin Res Pract. 2014;26(8):221—231 [Online]. Available: https://europepmc.org/abstract/MED/25860638.

  6. Birke JA, Patout CAJ, Foto JG. Factors associated with ulceration and amputation in the neuropathic foot. J Orthop Sports Phys Ther. 2000;30(2):91–7. https://doi.org/10.2519/jospt.2000.30.2.91.

    Article  CAS  PubMed  Google Scholar 

  7. Bus SA, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):e3269. https://doi.org/10.1002/dmrr.3269.

    Article  PubMed  Google Scholar 

  8. Rayman G, et al. The Ipswich touch test. Diabetes Care. 2011;34(7):1517–8. https://doi.org/10.2337/dc11-0156.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sharma S, Kerry C, Atkins H, Rayman G. The Ipswich touch test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Diabet Med. 2014;31(9):1100–3. https://doi.org/10.1111/dme.12450.

    Article  CAS  PubMed  Google Scholar 

  10. Dros J, Wewerinke A, Bindels PJ, van Weert HC. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Fam Med. 2009;7(6):555–8. https://doi.org/10.1370/afm.1016.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Tan LS. The clinical use of the 10g monofilament and its limitations: a review. Diabetes Res Clin Pract. 2010;90(1):1–7. https://doi.org/10.1016/j.diabres.2010.06.021.

    Article  PubMed  Google Scholar 

  12. Wang F, et al. Diagnostic accuracy of monofilament tests for detecting diabetic peripheral neuropathy: a systematic review and meta-analysis. J Diabetes Res. 2017;2017:8787261. https://doi.org/10.1155/2017/8787261.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Whiting PF, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36. https://doi.org/10.7326/0003-4819-155-8-201110180-00009.

    Article  PubMed  Google Scholar 

  14. Bowling FL, Abbott CA, Harris WE, Atanasov S, Malik RA, Boulton AJM. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting. Diabet Med. 2012;29(12):1550–2. https://doi.org/10.1111/j.1464-5491.2012.03730.x.

    Article  CAS  PubMed  Google Scholar 

  15. Madanat A, Sheshah E, Badawy E-B, Abbas A, AL-Bakheet A. Utilizing the Ipswich touch test to simplify screening methods for identifying the risk of foot ulceration among diabetics: the Saudi experience. Prim Care Diabetes. 2015;9(4):304–6. https://doi.org/10.1016/j.pcd.2014.10.007.

    Article  PubMed  Google Scholar 

  16. Dutra LMA, et al. Is it possible to substitute the monofilament test for the Ipswich touch test in screening for peripheral diabetic neuropathy? Diabetol Metab Syndr. 2020;12(1):27. https://doi.org/10.1186/s13098-020-00534-2.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Health. 2017;5:307. https://doi.org/10.3389/fpubh.2017.00307.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Sima AAF, Kamiya H. Diabetic neuropathy differs in Type 1 and Type 2 diabetes. Ann NY Acad Sci. 2006;1084(1):235–49. https://doi.org/10.1196/annals.1372.004.

    Article  PubMed  Google Scholar 

  19. Myers MI, Peltier AC. Uses of skin biopsy for sensory and autonomic nerve assessment. Curr Neurol Neurosci Rep. 2012;13(1):323. https://doi.org/10.1007/s11910-012-0323-2.

    Article  Google Scholar 

  20. National Institute for Health and Care Excellence (NICE). Diabetic foot problems: prevention and management. Natl. Inst. Heal. Care Excell. Clin. Guidel., Aug. 2015.

  21. American Diabetes Association. 10. Microvascular complications and foot care: standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S105 LP–S118 LP118 LP. https://doi.org/10.2337/dc18-S010.

    Article  Google Scholar 

  22. Feng Y, Schlösser FJ, Sumpio BE. The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus. J Vasc Surg. 2011;53(1):220–226.e5. https://doi.org/10.1016/j.jvs.2010.06.100.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arnold Hu.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Human rights statement

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, A., Koh, B. & Teo, M.R. A review of the current evidence on the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus. Diabetol Int 12, 145–150 (2021). https://doi.org/10.1007/s13340-020-00451-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-020-00451-9

Keywords

Navigation